Is adjunctive pharmacotherapy in attention-deficit/hyperactivity disorder cost-effective in Canada: a cost-effectiveness assessment of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant for the treatment of ADHD

BMC Psychiatry
Jean LachaineKarine Mathurin

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is a common psychiatric disorder in children, with worldwide prevalence of ADHD varying from 5.9 to 7.1 %, depending on the reporter. In case of inadequate response to stimulants, combination therapy of stimulants and an adjunctive medication may improve the control of ADHD symptoms, reduce the dose-limiting adverse events, and help control comorbidities. To date, the only medication to be used for adjunctive therapy to psychostimulants is guanfacine extended release (GXR). The aim of this study was to assess the economic impact of GXR as an adjunct therapy with long-acting stimulants (GXR + stimulant) compared to long-acting stimulant monotherapy (stimulant alone) in the treatment of children and adolescents with ADHD in Canada. A Markov model was developed using health states defined based on the clinician-reported Clinical Global Impression-Severity (CGI-S) score (normal, mild, moderate, severe). Transition probabilities were calculated based on patient-level data from a published study. Long-acting stimulants available in Canada were considered in the base-case model: amphetamine mixed salts, methylphenidate HCl formulations, and lisdexamfetamine dimesylate. Analyses were cond...Continue Reading

References

Jan 1, 1997·Journal of the American Academy of Child and Adolescent Psychiatry·J BiedermanJ Soriano
Sep 18, 1997·Journal of the American Academy of Child and Adolescent Psychiatry·S MannuzzaM E Hynes
Aug 14, 2001·Pharmacoepidemiology and Drug Safety·A Gilmore, R Milne
Sep 14, 2006·Current Psychiatry Reports·Lenard A AdlerTimothy E Wilens
May 8, 2007·European Child & Adolescent Psychiatry·L Hakkaart-van RoijenJ K Buitelaar
Jul 3, 2009·International Journal of Clinical Practice·S PrasadS E Libretto
Dec 20, 2011·Journal of the American Academy of Child and Adolescent Psychiatry·Timothy E WilensSharon Youcha
Feb 22, 2012·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Marie-Christine Brault, Éric Lacourse
Jun 14, 2012·Postgraduate Medicine·Jean LachainePaul S Hodgkins
Jul 4, 2012·International Archives of Occupational and Environmental Health·Thomas KüpperBarbara Schauble
Sep 15, 2012·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Erik G Willcutt
Oct 2, 2012·Journal of the American Academy of Child and Adolescent Psychiatry·Jalpa A DoshiPeter J Neumann

❮ Previous
Next ❯

Software Mentioned

OCCI Costing Analysis Tool

Related Concepts

Related Feeds

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.